Levothyroxine and Liothyronine — Class I drug recall D-1182-2018
Terminated recall by Westminster Pharmaceuticals LLC, reported 2018-08-29, distributed nationwide. Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical
| Recall number | D-1182-2018 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Westminster Pharmaceuticals LLC, Olive Branch, MS, United States |
| Recall initiated | 2018-08-03 |
| Classified | 2018-09-07 |
| Reported by FDA | 2018-08-29 |
| Terminated | 2020-06-03 |
| Distributed | Nationwide (US) |
| Reason classes | labeling, potency, cgmp |
| NDC | 69367-0158-04 |
| Lot numbers | 15817VP-01, 15817VP-02, 15817VP-03, 15818001 |
| Expiration dates | 2019-09-30, 2020-03-31 |
Product
Levothyroxine and Liothyronine (Thyroid Tablets, USP), 2 grain (120 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-158-04.
Reason for recall
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1182-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.